Chronic Disease Management

Overview:

Corstrata offers a comprehensive technology-enabled care management solution for persons with chronic wounds including diabetics at risk for formation of costly diabetic foot ulcers and related amputations resulting in improved clinical outcomes at a lower cost.

Company description:

Chronic wounds affect 6.5M in the U.S. at a cost of $33B. Corstrata’s technology enabled care management solution creates access to board-certified wound care and ostomy experts to improve clinical outcomes and reduce costs.

Using mobile technologies, Corstrata provides wound image and video consults with recommended evidenced based protocols. Additionally, Corstrata’s Diabetic Foot Ulcer and Amputation Prevention Solution utilizes a smart thermography mat and a patient engagement app to engage high-risk diabetics and prevent Diabetic Foot Ulcers (DFU) for the 1.7M suffering with one or more DFU annually and the 80K of these diabetics who ultimately require an amputation.

Joseph Ebberwein

Founder/CFO

Call 617.863.0108 to inquire

I am seeking to meet Angel/Seed Round Investors and Insurance Payers/Self-Funded Plan executives.

Company name: Corstrata, Inc.

Date founded: August 2015

Contact:

Joseph Ebberwein,

Founder/CFO

Funding to date: N/A

Financing sought: N/A

Current investors: N/A

Website URL: www.corstrata.com

Facebook: @Corstrata

Twitter: @Corstrata

LinkedIn: company/corstrata/

Pitch URL: N/A